RetinaRisk is a healthTech company founded by world-renowned team of visionary doctors to transform the future of healthcare by providing personalized care based on individualized risk assessment.The clinically validated RetinaRisk algorithm empowers the 463 million people living with diabetes around the world to calculate their individualized risk of developing sight-threatening diabetic retinopathy, one of the leading causes of blindness in the world. RetinaRisk was developed by Dr. Einar Stefansson, Professor at the Department of Ophthalmology, University of Iceland and Dr. Arna Gudmundsdottir, Endocrinologist at the National Hospital Reykjavik, who have over 30 years’ experience in screening for diabetic retinopathy and treating diabetes. RetinaRisk algorithm is based on extensive international research and has been clinically validated in over 25.000 diabetic patients in five countries and found to be extremely robust. It allows healthcare providers to identify high-risk patients who need immediate care to prevent vision loss. RetinaRisk is focused on wellness, prevention and personalization through digital engagement and predictive analytics. We’re witnessing the rise of digital health and fundamental changes in healthcare with patients becoming more knowledgeable and active participants in their wellness journey. RetinaRisk offers a truly personalized approach leading to the right patient receiving the right treatment at the right time.